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Abstract. The possibility that erythrocytes may function as a reservoir for noradrenaline and adrenaline and as a modulator
of circulating catecholamine concentrations had been suggested. The aim of this work was to study the adrenaline effect on
erythrocyte membrane fluidity, acetylcholinesterase (AChE) enzyme activity, P50 and erythrocyte deformability and also to
verify if the role of adrenaline on erythrocyte properties is sex-dependent. Blood samples from 42 healthy donors were obtained,
and its aliquots incubated 30 min without (control) and with 10−5 M concentrations of adrenaline alone (A1) and adrenaline
with an α and an β-blocker (A2). Results demonstrate that initial AChE values in female are higher (p  0.01) than male values.
In female, adrenaline decreases AChE activity either when α and β-adrenergic receptors are blocked (p  0.01) or when they
are not. In male, adrenaline increases AChE activity when none of adrenergic receptors are blocked. Control values of male
and female erythrocyte membrane fluidity are very similar but behaviour became differently (p  0.05) when adrenaline is
present because it decreases male and increases female values. Gender differences in erythrocyte deformability are verified
at high shear stress values (p  0.02). In female we have also registered the existence of an inverse significant correlation
(r = −0.62) between membrane rigidity and AChE activity in A2 values. Adrenaline increases p50 values (p  0.03) in both
sexes. Peripheral blood film has shown echinocytes when adrenaline 10−5 M is present. We conclude that in this in vitro study
sex-related differences in erythrocyte acetylcholinesterase enzyme activity, membrane fluidity and erythrocyte deformability
under adrenaline influence were found.
Keywords: Adrenaline, erythrocyte, erythrocyte membrane fluidity, acetylcholinesterase enzyme activity, P50, erythrocyte
deformability, gender
1. Introduction
Several authors have suggested that erythrocytes are involved in the sequestration and inactivation of
circulating catecholamines and thus in the modulation of adrenaline concentrations [29] which may have
implications on the blood vessels tonus regulation of microcirculation. When incubated “in vitro” at 37◦C
these blood cells accumulate cathecolamines against a concentration gradient. The uptake process was
temperature dependent and saturable, both phenomena characterising an active transport system [1,4].
The possibility that erythrocytes may function as a reservoir for adrenaline had also been suggested [4].
Others have proposed a direct influence of cathecolamines on erythrocyte functions and properties [29].
A considerable fraction of circulating catecholamines is bound to a specific high-affinity serum protein
and a small fraction is also taken up by platelets [29].
We have also based our work on taking into account the presence on the erythrocyte membrane of
functional β and α adrenergic receptors with which adrenaline can interact [10,14,16,30]. Besides, in
the outer leaflet of the erythrocyte membrane is registered the existence of an important protein that
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contribute for the membrane integrity called acetylcholinesterase (AChE). Anchored to the erythrocyte
membrane through a covalently linked glycolipid residue, this enzyme is reported by several investigators
as been modulated by lipid environment and other membrane surface phenomena [26].
Another important property of erythrocyte, considered as a hemorheologic factor, is its deformability
required for normal passage of erythrocytes through the capillaries [7]. The deformability of the normal
human erythrocyte is a consequence of its low cytoplasmatic viscosity, its excess of surface membrane
area in relation to cell volume, and its viscoelastic cell membrane [11]. The erythrocyte membrane cy-
toskeleton has also a valorous role on erythrocyte deformability. Haemoglobin is able to bind to those
cytoskeletal elements and is responsible for the transport of oxygen to tissues. The haemoglobin affinity
to oxygen is experimental measured and referred as P50 values.
Even though all the erythrocyte studies it is hard to believe that only a little is known about eventual
membrane erythrocyte properties and functions differences between gender.
The aim of this work was to study the effect of adrenaline 10−5 M on red blood cell properties namely
erythrocyte membrane fluidity, erythrocyte acetylcholinesterase (AChE) enzyme activity, P50 values and
erythrocyte deformability and to verify if the role of adrenaline on red blood cell properties is sex-
dependent.
2. Material and methods
2.1. Subjects
In order to achieve the aim of our work, we have selected 42 Caucasians healthy donors (21 males
and 21 females) after their voluntary approval. The average age was of 24 ± 2 years old and the mean
haemoglobin values was of 16.40 ± 0.8 g/dl in males and 13.10 ± 0.5 g/dl in females.
We have considered the following exclusion parameters: the existence of diseases or clinical syn-
dromes related to blood or metabolism, the existence of present medication, more precisely β-agonists
and β-blockers or even alcohol intake.
2.2. Blood sampling aliquots and incubation procedure
The experimental approach of blood sample aliquots is presented in the Fig. 1.
Venous blood (3 ml) was obtained after 15 minutes in the recumbent position and collected in tubes
with heparin (10 U/ml) as anticoagulant [13]. Total blood was divided in 3 aliquots of 1 ml each and
then we centrifuged at 12 000 rpm (5414 Centrifuge Eppendorf R©, Sotel) during a short period time of
1 minute. After this procedure 10 µl of plasma were replaced by the same amount of α and β-agonist or
α and β-blockading as represented in Table 1, so that the final plasma concentration of the effectors was
10−5 M. All aliquots were incubated 30 minutes at room temperature.
We have chosen adrenaline for α and β-agonist because it is an ubiquitous physiological molecule.
Nadolol was used as β-blockading and tolazoline as α-blockading. Both these latter substances do not
have intrinsic adrenergic activity, are competitive and specific blockading and have a rather low lipid
partition coefficient.
2.3. Measurements
Erythrocyte acetylcholinesterase (AChE) enzyme activity – Determined by Ellman’ spectrophotometric
method modified by Kaplan et al. [5]. This enzyme could be an index expresses of membrane integrity.
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Fig. 1. Schematic representation of blood samples aliquots manipulation in absence and presence of effectors (adrenaline
10−5 M, tolazoline 10−5 M and nadolol 10−5 M) in order to further biochemical parameters determinations (erythrocyte
acetylcholinesterase enzymatic activity, erythrocyte membrane fluidity, erythrocyte deformability) – see text.
Erythrocyte membrane lipid fluidity – Membrane fluidity is usually defined as the mobility status of
the membrane lipids. In this work we want to study only hydrophobic membrane fluidity, determined
by the method of fluorescence polarization with a probe (1,6-biphenyl-1,3,5-hexatriene or DPH) to hy-
drophobic region of membrane. Increased values of fluorescence polarization obtained with DPH means
decreased membrane lipid fluidity ability (or the inverse which means increased rigidity) [6]. All the
fluorescence spectroscopy measurements were carried out in a Hitachi F-3000 fluorescence spectropho-
tometer (Tokyo, Japan) and the fluorescence polarization intensities recorded at excitation wavelength of
352 nm and emission wavelength of 430 nm.
Erythrocyte deformability – Depends mainly on three variables: cytoplasm viscosity, membrane stiff-
ness and the favourable surface to volume ratio. The results were reading in a Myrenne gmbh rheodyn
SSD shear stress diffractometer [27,28].
P50 is the partial pressure of oxygen that half-saturates haemoglobin and was determined in HemoxTM-
Analyser.
M.C.H.C. (mean cell haemoglobin concentration) – Obtained from the quotient between haemoglobin
concentration values and the haematocrit ones. Haemoglobin was measured in OsmTM 3 HemoximeterTM
[17]. Haematocrit was performed by mycrohaematocrit method in ALC 4223 Centrifuge [17].
Peripheral blood films were performed from all aliquots, using May–Grunwald–Giemsa coloration.
2.4. Statistical analysis
Results are expressed as mean value ± standard deviation.
The unpaired Student t-test was performed to estimate the statistical significance of differences be-
tween the values of parameters measured of male and female blood. The null hypothesis was rejected for
a significance level of p = 0.05.
Correlation among all the variables considered was done.
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Table 1
Values (mean value ± standard deviation) of the erythrocyte acetylcholinesterase (AChE), fluorescence polarization (determined with DPH), erythrocyte deforma-
bility, CMHG, P50, obtained in blood sample aliquots of both sexes in absence (control) and presence of adrenaline 10−5 M alone (A1) or together with tolazoline
and nadolol (A2)
AChE DPH (nd) Erythrocyte Erythrocyte CMHG P50
(units/min/mgHb) deformability 6 Pa deformability 30 Pa
Control 285.7± 15.1a,b 0.298± 0.03 5.12± 1.7 49.9± 4.4c 35.2± 1.6 32.07± 2.012a
aliquot
Female A1 276.1± 17.4 0.317± 0.03a 5.56± 1.9 50.2± 4.5a 36.1± 1.7 34.9± 3.53a
A2 247.6± 17.1b 0.284± 0.06 4.65± 1.7 49.3± 4.3b 34.7± 1.7 –
Control 230.8± 16.2a 0.298± 0.03 4.59± 1.8 45.6± 6.2c 36.1± 1.06 30.8± 1.29b
aliquot
Male A1 260.1± 15.2 0.278± 0.04a 4.57± 1.8 45.4± 5.6a 35.1± 1.3 32.04± 5.39b
A2 236.2± 16.5 0.288± 0.03 3.29± 1.1 43.5± 5.8b 35± 1.06 –
p 0.01 0.05 ns 0.02 ns 0.05
a,b,cMeaning statistically significant as following: AChE – a: female control aliquots vs male control aliquot; b: female A2 vs female control aliquot. DPH –
a: female A1 vs male A1. Erythrocyte deformability 30 Pa – a: female A1 vs male A1; b: female A2 vs male A2; c: female control aliquot vs male control aliquot.
P50 – a: female A1 vs female control aliquot; b: male A1 vs male control aliquot.
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3. Results
The summary of the results obtained after blood aliquots manipulation as described above in material
and methods is shown in Table 1.
3.1. Erythrocyte AChE enzyme activity
The results obtained show that initial erythrocyte AChE activity female values (285.7±15.1 u/min/mg
Hb) were significantly higher (p  0.01) than male values (230.8 ± 16.2 u/min/mg Hb). In female, in
comparison to control, adrenaline 10−5 M decreases significantly (p  0.01) AChE activity when α and
β-adrenergic receptors are blocked (247.6±17.1 u/min/mg Hb vs 285.7±15.1 u/min/mg Hb) but the dif-
ference have no statistical significance when they are not blocked (276.1±17.4 u/min/mg Hb vs 285.7±
15.1 u/min/mg Hb). In male, adrenaline seams to increase (but not significantly) AChE when none of
adrenergic receptors are blocked (260.1 ± 15.2 u/min/mg Hb vs 230.8 ± 16.2 u/min/mg Hb; Fig. 2).
3.2. Erythrocyte membrane lipid fluidity
Control values of male and female membrane fluidity are very similar (male: 0.2982±0.03 nd; female:
0.2986 ± 0.03 nd). These values are different (p  0.05) after adding adrenaline because it increases
female (0.317 ± 0.03 nd) and decreases male DPH values (0.278 ± 0.04 nd; Fig. 3). It means that
adrenaline 10−5 M increases female erythrocyte membrane rigidity and, in other hand, increases male
erythrocyte membrane fluidity.
In female we have also registered the existence of an inverse significant correlation (r = −0.62)
between membrane rigidity and AChE activity in A2, which means that in female with an increase
of membrane hydrophobic region rigidity we may expect a decrease of that enzyme activity if both
adrenergic receptors were blocked.
Fig. 2. Mean values and standard deviation of erythrocyte acetylcholinesterase activity in 42 blood samples (male: 21; female:
21) in absence (control) and presence of adrenaline [10−5 M] alone (A1) or together with tolazoline [10−5 M] + nadolol
[10−5 M] (A2). Statistically significantly to p  0.01 (∗).
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Fig. 3. Mean values and standard deviation of fluorescence polarization obtained with the probe DPH in 42 blood samples (male:
21; female: 21) in absence (control) and presence of adrenaline [10−5 M] alone (A1) or together with tolazoline [10−5 M] +
nadolol [10−5 M] (A2). Statistically significantly to p  0.05 (∗).
Fig. 4. Mean values of erythrocyte deformability to 0.6; 6 and 30 shear stress in 30 blood samples (male: 15; female: 15) in
absence (control) and presence of adrenaline [10−5 M] alone (A1) or together with tolazoline [10−5 M] + nadolol [10−5 M]
(A2). Statistically significantly to p  0.05 (∗) and to p  0.01 (#).
3.3. Erythrocyte deformability
As we can see in Fig. 4, erythrocyte deformability gender differences (p  0.02) are found, although at
high shear stress values only. This fact is verified in absence (Control) and presence of adrenaline alone
(A1) or together with adrenergic blockers (A2).
3.4. P50 values
Figure 5 compares male and female P50 blood values in presence of adrenaline to those without that
catecholamine. The difference between these values is statistically significant (p  0.01) in both sexes.
MCHC values were not statistically different between male and female blood aliquots.
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Fig. 5. Mean values and standard deviation of erythrocyte P50 values in 42 blood samples (male: 21; female: 21) in absence
(control) and presence of adrenaline [10−5 M] (A1). Statistically significantly to p  0.01 (∗).
Fig. 6. Peripheral blood film (control).
3.5. Peripheral blood films
In the control peripheral blood film we can see normal shapes of erythrocytes or a very little number of
echinocytes but when adrenaline 10−5 M is present the peripheral blood film have shown a large number
of echinocytes (Figs 6 and 7).
4. Discussion
In our in vitro study we were able to show that adrenaline 10−5 M increases erythrocyte P50 val-
ues (Table 1) which means a decrease of haemoglobin affinity to oxygen. This fact may be understood
in accordance with results of other study that had shown an increase of 2,3-biphosphoglicerate (2,3-
BPG) in presence of adrenaline [24]. It is well known that 2,3-BPG is a negative modulator of oxy-
gen haemoglobin affinity thus the experimental increased p50 values confirms this metabolic effect of
adrenaline.
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Fig. 7. Echinocytes in the peripheral blood film, under effect of adrenaline.
Adrenaline 10−5 M seams to be responsible for the existence of echinocytes in peripheral blood film
in both sexes (Fig. 6) which could result from alterations of adenosine triphosphate (ATP) content or pH
modifications (work in study).
The gender differences observed in erythrocyte deformability at high shear stress values may not be
explained by different internal viscosity because MCHC is similar between women and men. Thus, other
erythrocyte properties must be studied (membrane stiffness and surface to volume ratio) to explain these
results. On other hand, attending to the erythrocyte deformation values obtained in both sexes at low
shear stress, we think that erythrocyte membrane flexibility in female is near close of male one.
In this work we also found sex-related differences in AChE enzymatic activity and membrane fluidity
under adrenaline 10−5 M influence. Besides the increase of male AChE enzymatic activity values in
presence of adrenaline or the decrease of that values in female, the true is that if both β and α adrenergic
receptors are blocked we find the same profile of decreasing AChE enzymatic activity under adrenaline
influence in both sexes. These results are in accordance with purified AChE studies described of our
laboratory (not published) who stated a decrease in purified AChE activity in presence of adrenaline. If
these phenomena have any relation with a direct binding of adrenaline to the native form (erythrocyte
intact) of the enzyme is a matter of more sophisticated methodological approach.
The profile of erythrocyte membrane fluidity under adrenaline influence is the opposite of that one
observed in AChE activity either in male or in female (Fig. 3). This fact forces us to think that this
catecholamine may interact with erythrocyte membrane and then interfering with AChE activity inde-
pendently of sexes. According with this theory is the external membrane localization of AChE that makes
it vulnerable not only to the effects of some molecules in the blood circulation but also that ones that
could interfere with the structure molecular organisation state of the membrane.
The discovery of sex-related differences in erythrocyte AChE activity and in the membrane hydropho-
bic region fluidity under adrenaline influence only if β and α adrenergic receptors are free is a fact
never described in the literature, as far as we know. These molecular and functional differences ob-
tained with human erythrocyte in this study could contribute to understand different responses, attitudes
and behaviours to stress situations verified usually between sexes. The existence of sexually determined
characteristics, at the cellular level, have important implications that may influence how we are affected
by disease and medication, the respective tissues responses to these situations and even how long we live.
It is known that drugs side effects are of different severity depending on gender, besides some drugs are
more effective in women [22].
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It has became increasingly clear that to improve medicine for both sexes, more studies need to be
done to know molecular differences between male and female and to determine how sex influences
susceptibility to disease and functioning of organs and organ systems. Agree to that is Pardue, who says
that being male or female encompasses far more than reproductive systems and hormones [22].
Sex appears to play a role in the severity and incidence of several diseases, including heart disease
[18], obesity, and rheumatoid arthritis. Some authors registered differences between pre-menopausal
women and age-matched men in morbidity from cardiac diseases and especially from myocardial infarc-
tion [21]. To this fact may also contribute differences in haemorheological properties like erythrocyte
aggregation [3,21]. Other data points to more pronounced haemorheological and humoral abnormalities
in men than in women with essential hypertension that may also contribute to the increased incidence of
cardiovascular events in men [8].
Animal and humans studies demonstrated that also some vascular responses are affected by the sex of
the study subject [2,12,17–20], like contraction of carotid arteries to serotonin (that seems to be enhanced
in female mice) or even endothelium-derived NO-dependent vasodilatation enhanced by oestrogen in up
regulating NO synthase [21,25,31].
These kinds of studies must be continued in order to improve therapies, even that means the use
of different molecules to treat the same pathology depending of gender. Is known from literature that
adrenaline infusion and exercise induce activation of haemostasis [31] but it would be more interesting
to study possible different biochemical responses to stress between women and men that may explain
apparent social different behaviours.
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